2015-2027 Global Beta-Thal Disease Industry Market Research Report, Segment by Player, Type, Application, Marketing Channel, and Region

May 2020 | 140 pages | ID: 280D8FDBB00EEN
Maia Research

Abstracts

The worldwide market for Beta-Thal Disease is estimated to grow at a CAGR of roughly X.X% in the next 8 years, and will reach X.X million US$ in 2027, from X.X million US$ in 2020.

The report covers market size status and forecast, value chain analysis, market segmentation of Top countries in Major Regions, such as North America, Europe, Asia-Pacific, Latin America and Middle East & Africa, by type, application and marketing channel. In addition, the report focuses on the driving factors, restraints, opportunities and PEST analysis of major regions.

Major Companies Covered
La Jolla Pharmaceutical Company
Acceleron Pharma, Inc.
Gamida Cell
Celgene Corporation
Incyte Corporation
bluebird bio, Inc.
Kiadis Pharma
IONIS Pharmaceuticals
GlaxoSmithKline plc

Major Types Covered
Iron Chelating Drugs
Gene Therapy

Major Applications Covered
Hospitals
Biotechnological Laboratories
Diagnostic Laboratories

Top Countries Data Covered in This Report
United States
Canada
Germany
UK
France
Italy
Spain
Russia
Netherlands
Turkey
Switzerland
Sweden
Poland
Belgium
China
Japan
South Korea
Australia
India
Taiwan
Indonesia
Thailand
Philippines
Malaysia
Brazil
Mexico
Argentina
Columbia
Chile
Saudi Arabia
UAE
Egypt
Nigeria
South Africa

Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2027

Contents

1 INTRODUCTION

1.1 Objective of the Study
1.2 Definition of the Market
1.3 Market Scope
  1.3.1 Market Segment by Type, Application and Marketing Channel
  1.3.2 Major Regions Covered (North America, Europe, Asia Pacific, Mid East & Africa)
1.4 Years Considered for the Study (2015-2027)
1.5 Currency Considered (U.S. Dollar)
1.6 Stakeholders

2 KEY FINDINGS OF THE STUDY

3 MARKET DYNAMICS

3.1 Driving Factors for this Market
3.2 Factors Challenging the Market
3.3 Opportunities of the Global Beta-Thal Disease Market (Regions, Growing/Emerging Downstream Market Analysis)
3.4 Technological and Market Developments in the Beta-Thal Disease Market
3.5 Industry News by Region
3.6 Regulatory Scenario by Region/Country
3.7 Market Investment Scenario Strategic Recommendations Analysis

4 VALUE CHAIN OF THE BETA-THAL DISEASE MARKET

4.1 Value Chain Status
4.2 Upstream Raw Material Analysis
4.3 Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
4.4 Distributors/Traders
4.5 Downstream Major Customer Analysis (by Region)

5 GLOBAL BETA-THAL DISEASE MARKET-SEGMENTATION BY TYPE

5.1 Iron Chelating Drugs
5.2 Gene Therapy

6 GLOBAL BETA-THAL DISEASE MARKET-SEGMENTATION BY APPLICATION

6.1 Hospitals
6.2 Biotechnological Laboratories
6.3 Diagnostic Laboratories

7 GLOBAL BETA-THAL DISEASE MARKET-SEGMENTATION BY MARKETING CHANNEL

7.1 Traditional Marketing Channel (Offline)
7.2 Online Channel

8 COMPETITIVE INTELLIGENCE – COMPANY PROFILES

8.1 La Jolla Pharmaceutical Company
  8.1.1 La Jolla Pharmaceutical Company Profile
  8.1.2 La Jolla Pharmaceutical Company Sales, Growth Rate and Global Market Share from 2015-2020
  8.1.3 La Jolla Pharmaceutical Company Product/Solution Launches and Enhancements Analysis
  8.1.4 La Jolla Pharmaceutical Company Business Overview/Recent Development/Acquisitions
8.2 Acceleron Pharma, Inc.
  8.2.1 Acceleron Pharma, Inc. Profile
  8.2.2 Acceleron Pharma, Inc. Sales, Growth Rate and Global Market Share from 2015-2020
  8.2.3 Acceleron Pharma, Inc. Product/Solution Launches and Enhancements Analysis
  8.2.4 Acceleron Pharma, Inc. Business Overview/Recent Development/Acquisitions
8.3 Gamida Cell
  8.3.1 Gamida Cell Profile
  8.3.2 Gamida Cell Sales, Growth Rate and Global Market Share from 2015-2020
  8.3.3 Gamida Cell Product/Solution Launches and Enhancements Analysis
  8.3.4 Gamida Cell Business Overview/Recent Development/Acquisitions
8.4 Celgene Corporation
  8.4.1 Celgene Corporation Profile
  8.4.2 Celgene Corporation Sales, Growth Rate and Global Market Share from 2015-2020
  8.4.3 Celgene Corporation Product/Solution Launches and Enhancements Analysis
  8.4.4 Celgene Corporation Business Overview/Recent Development/Acquisitions
8.5 Incyte Corporation
  8.5.1 Incyte Corporation Profile
  8.5.2 Incyte Corporation Sales, Growth Rate and Global Market Share from 2015-2020
  8.5.3 Incyte Corporation Product/Solution Launches and Enhancements Analysis
  8.5.4 Incyte Corporation Business Overview/Recent Development/Acquisitions
8.6 bluebird bio, Inc.
  8.6.1 bluebird bio, Inc. Profile
  8.6.2 bluebird bio, Inc. Sales, Growth Rate and Global Market Share from 2015-2020
  8.6.3 bluebird bio, Inc. Product/Solution Launches and Enhancements Analysis
  8.6.4 bluebird bio, Inc. Business Overview/Recent Development/Acquisitions
8.7 Kiadis Pharma
  8.7.1 Kiadis Pharma Profile
  8.7.2 Kiadis Pharma Sales, Growth Rate and Global Market Share from 2015-2020
  8.7.3 Kiadis Pharma Product/Solution Launches and Enhancements Analysis
  8.7.4 Kiadis Pharma Business Overview/Recent Development/Acquisitions
8.8 IONIS Pharmaceuticals
  8.8.1 IONIS Pharmaceuticals Profile
  8.8.2 IONIS Pharmaceuticals Sales, Growth Rate and Global Market Share from 2015-2020
  8.8.3 IONIS Pharmaceuticals Product/Solution Launches and Enhancements Analysis
  8.8.4 IONIS Pharmaceuticals Business Overview/Recent Development/Acquisitions
8.9 GlaxoSmithKline plc
  8.9.1 GlaxoSmithKline plc Profile
  8.9.2 GlaxoSmithKline plc Sales, Growth Rate and Global Market Share from 2015-2020
  8.9.3 GlaxoSmithKline plc Product/Solution Launches and Enhancements Analysis
  8.9.4 GlaxoSmithKline plc Business Overview/Recent Development/Acquisitions

9 GLOBAL BETA-THAL DISEASE MARKET-SEGMENTATION BY GEOGRAPHY

10 NORTH AMERICA

10.1 North America Beta-Thal Disease Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
10.2 North America Beta-Thal Disease Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
10.3 North America Beta-Thal Disease Production Analysis from 2015-2020
10.4 North America Beta-Thal Disease Consumption Analysis from 2015-2020
10.5 North America Beta-Thal Disease Import and Export from 2015-2020
10.6 North America Beta-Thal Disease Value, Production and Market Share by Type (2015-2020)
10.7 North America Beta-Thal Disease Consumption, Value and Market Share by Application (2015-2020)
10.8 North America Beta-Thal Disease by Country (United States, Canada)
  10.8.1 North America Beta-Thal Disease Sales by Country (2015-2020)
  10.8.2 North America Beta-Thal Disease Consumption Value by Country (2015-2020)
10.9 North America Beta-Thal Disease Market PEST Analysis

11 EUROPE

11.1 Europe Beta-Thal Disease Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
11.2 Europe Beta-Thal Disease Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
11.3 Europe Beta-Thal Disease Production Analysis from 2015-2020
11.4 Europe Beta-Thal Disease Consumption Analysis from 2015-2020
11.5 Europe Beta-Thal Disease Import and Export from 2015-2020
11.6 Europe Beta-Thal Disease Value, Production and Market Share by Type (2015-2020)
11.7 Europe Beta-Thal Disease Consumption, Value and Market Share by Application (2015-2020)
11.8 Europe Beta-Thal Disease by Country (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden, Poland, Belgium)
  11.8.1 Europe Beta-Thal Disease Sales by Country (2015-2020)
  11.8.2 Europe Beta-Thal Disease Consumption Value by Country (2015-2020)
11.9 Europe Beta-Thal Disease Market PEST Analysis

12 ASIA-PACIFIC

12.1 Asia-Pacific Beta-Thal Disease Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
12.2 Asia-Pacific Beta-Thal Disease Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
12.3 Asia-Pacific Beta-Thal Disease Production Analysis from 2015-2020
12.4 Asia-Pacific Beta-Thal Disease Consumption Analysis from 2015-2020
12.5 Asia-Pacific Beta-Thal Disease Import and Export from 2015-2020
12.6 Asia-Pacific Beta-Thal Disease Value, Production and Market Share by Type (2015-2020)
12.7 Asia-Pacific Beta-Thal Disease Consumption, Value and Market Share by Application (2015-2020)
12.8 Asia-Pacific Beta-Thal Disease by Country (China, Japan, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines, Malaysia)
  12.8.1 Asia-Pacific Beta-Thal Disease Sales by Country (2015-2020)
  12.8.2 Asia-Pacific Beta-Thal Disease Consumption Value by Country (2015-2020)
12.9 Asia-Pacific Beta-Thal Disease Market PEST Analysis

13 LATIN AMERICA

13.1 Latin America Beta-Thal Disease Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
13.2 Latin America Beta-Thal Disease Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
13.3 Latin America Beta-Thal Disease Production Analysis from 2015-2020
13.4 Latin America Beta-Thal Disease Consumption Analysis from 2015-2020
13.5 Latin America Beta-Thal Disease Import and Export from 2015-2020
13.6 Latin America Beta-Thal Disease Value, Production and Market Share by Type (2015-2020)
13.7 Latin America Beta-Thal Disease Consumption, Value and Market Share by Application (2015-2020)
13.8 Latin America Beta-Thal Disease by Country (Brazil, Mexico, Argentina, Columbia, Chile)
  13.8.1 Latin America Beta-Thal Disease Sales by Country (2015-2020)
  13.8.2 Latin America Beta-Thal Disease Consumption Value by Country (2015-2020)
13.9 Latin America Beta-Thal Disease Market PEST Analysis

14 MIDDLE EAST & AFRICA

14.1 Middle East & Africa Beta-Thal Disease Production, Ex-factory Price, Revenue, Gross Margin (%) and Gross Analysis from 2015-2020
14.2 Middle East & Africa Beta-Thal Disease Consumption, Terminal Price, Consumption Value and Channel Margin Analysis from 2015-2020
14.3 Middle East & Africa Beta-Thal Disease Production Analysis from 2015-2020
14.4 Middle East & Africa Beta-Thal Disease Consumption Analysis from 2015-2020
14.5 Middle East & Africa Beta-Thal Disease Import and Export from 2015-2020
14.6 Middle East & Africa Beta-Thal Disease Value, Production and Market Share by Type (2015-2020)
14.7 Middle East & Africa Beta-Thal Disease Consumption, Value and Market Share by Application (2015-2020)
14.8 Middle East & Africa Beta-Thal Disease by Country (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)
  14.8.1 Middle East & Africa Beta-Thal Disease Sales by Country (2015-2020)
  14.8.2 Middle East & Africa Beta-Thal Disease Consumption Value by Country (2015-2020)
14.9 Middle East & Africa Beta-Thal Disease Market PEST Analysis

15 FUTURE FORECAST OF THE GLOBAL BETA-THAL DISEASE MARKET FROM 2020-2027

15.1 Future Forecast of the Global Beta-Thal Disease Market from 2020-2027 Segment by Region
15.2 Global Beta-Thal Disease Production and Growth Rate Forecast by Type (2020-2027)
15.3 Global Beta-Thal Disease Consumption and Growth Rate Forecast by Application (2020-2027)

16 APPENDIX

16.1 Methodology
16.2 Research Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Global Beta-Thal Disease Market Value ($) and Growth Rate of Beta-Thal Disease from 2015-2027
Global Beta-Thal Disease Production and Growth Rate Segment by Product Type from 2015-2027
Global Beta-Thal Disease Consumption and Growth Rate Segment by Application from 2015-2027
Figure Beta-Thal Disease Picture
Table Product Specifications of Beta-Thal Disease
Table Driving Factors for this Market
Table Industry News of Beta-Thal Disease Market
Figure Value Chain Status of Beta-Thal Disease
Table Midstream Major Company Analysis (by Manufacturing Base, by Product Type)
Table Distributors/Traders
Table Downstream Major Customer Analysis (by Region, by Preference)
Table Global Beta-Thal Disease Production and Growth Rate Segment by Product Type from 2015-2020
Table Global Beta-Thal Disease Value ($) and Growth Rate Segment by Product Type from 2015-2020
Figure Iron Chelating Drugs of Beta-Thal Disease
Figure Gene Therapy of Beta-Thal Disease
Table Global Beta-Thal Disease Consumption and Growth Rate Segment by Application from 2015-2020
Table Global Beta-Thal Disease Value ($) and Growth Rate Segment by Application from 2015-2020
Figure Hospitals of Beta-Thal Disease
Figure Biotechnological Laboratories of Beta-Thal Disease
Figure Diagnostic Laboratories of Beta-Thal Disease
Table Global Beta-Thal Disease Consumption and Growth Rate Segment by Marketing Channel from 2015-2020
Table Global Beta-Thal Disease Value ($) and Growth Rate Segment by Marketing Channel from 2015-2020
Figure Traditional Marketing Channel (Offline) of Beta-Thal Disease
Figure Online Channel of Beta-Thal Disease
Table La Jolla Pharmaceutical Company Profile (Company Name, Plants Distribution, Sales Region)
Figure La Jolla Pharmaceutical Company Sales and Growth Rate from 2015-2020
Figure La Jolla Pharmaceutical Company Revenue ($) and Global Market Share from 2015-2020
Table La Jolla Pharmaceutical Company Beta-Thal Disease Sales, Price, Revenue, Gross Margin (2015-2020)
Table Acceleron Pharma, Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure Acceleron Pharma, Inc. Sales and Growth Rate from 2015-2020
Figure Acceleron Pharma, Inc. Revenue ($) and Global Market Share from 2015-2020
Table Acceleron Pharma, Inc. Beta-Thal Disease Sales, Price, Revenue, Gross Margin (2015-2020)
Table Gamida Cell Profile (Company Name, Plants Distribution, Sales Region)
Figure Gamida Cell Sales and Growth Rate from 2015-2020
Figure Gamida Cell Revenue ($) and Global Market Share from 2015-2020
Table Gamida Cell Beta-Thal Disease Sales, Price, Revenue, Gross Margin (2015-2020)
Table Celgene Corporation Profile (Company Name, Plants Distribution, Sales Region)
Figure Celgene Corporation Sales and Growth Rate from 2015-2020
Figure Celgene Corporation Revenue ($) and Global Market Share from 2015-2020
Table Celgene Corporation Beta-Thal Disease Sales, Price, Revenue, Gross Margin (2015-2020)
Table Incyte Corporation Profile (Company Name, Plants Distribution, Sales Region)
Figure Incyte Corporation Sales and Growth Rate from 2015-2020
Figure Incyte Corporation Revenue ($) and Global Market Share from 2015-2020
Table Incyte Corporation Beta-Thal Disease Sales, Price, Revenue, Gross Margin (2015-2020)
Table bluebird bio, Inc. Profile (Company Name, Plants Distribution, Sales Region)
Figure bluebird bio, Inc. Sales and Growth Rate from 2015-2020
Figure bluebird bio, Inc. Revenue ($) and Global Market Share from 2015-2020
Table bluebird bio, Inc. Beta-Thal Disease Sales, Price, Revenue, Gross Margin (2015-2020)
Table Kiadis Pharma Profile (Company Name, Plants Distribution, Sales Region)
Figure Kiadis Pharma Sales and Growth Rate from 2015-2020
Figure Kiadis Pharma Revenue ($) and Global Market Share from 2015-2020
Table Kiadis Pharma Beta-Thal Disease Sales, Price, Revenue, Gross Margin (2015-2020)
Table IONIS Pharmaceuticals Profile (Company Name, Plants Distribution, Sales Region)
Figure IONIS Pharmaceuticals Sales and Growth Rate from 2015-2020
Figure IONIS Pharmaceuticals Revenue ($) and Global Market Share from 2015-2020
Table IONIS Pharmaceuticals Beta-Thal Disease Sales, Price, Revenue, Gross Margin (2015-2020)
Table GlaxoSmithKline plc Profile (Company Name, Plants Distribution, Sales Region)
Figure GlaxoSmithKline plc Sales and Growth Rate from 2015-2020
Figure GlaxoSmithKline plc Revenue ($) and Global Market Share from 2015-2020
Table GlaxoSmithKline plc Beta-Thal Disease Sales, Price, Revenue, Gross Margin (2015-2020)
Table Global Beta-Thal Disease Production Value ($) by Region from 2015-2020
Table Global Beta-Thal Disease Production Value Share by Region from 2015-2020
Table Global Beta-Thal Disease Production by Region from 2015-2020
Table Global Beta-Thal Disease Consumption Value ($) by Region from 2015-2020
Table Global Beta-Thal Disease Consumption by Region from 2015-2020
Table North America Beta-Thal Disease Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table North America Beta-Thal Disease Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table North America Beta-Thal Disease Import and Export from 2015-2020
Table North America Beta-Thal Disease Value ($) by Type (2015-2020)
Table North America Beta-Thal Disease Production by Type (2015-2020)
Table North America Beta-Thal Disease Consumption by Application (2015-2020)
Table North America Beta-Thal Disease Consumption by Country (2015-2020)
Table North America Beta-Thal Disease Consumption Value ($) by Country (2015-2020)
Figure North America Beta-Thal Disease Market PEST Analysis
Table Europe Beta-Thal Disease Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Europe Beta-Thal Disease Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Europe Beta-Thal Disease Import and Export from 2015-2020
Table Europe Beta-Thal Disease Value ($) by Type (2015-2020)
Table Europe Beta-Thal Disease Production by Type (2015-2020)
Table Europe Beta-Thal Disease Consumption by Application (2015-2020)
Table Europe Beta-Thal Disease Consumption by Country (2015-2020)
Table Europe Beta-Thal Disease Consumption Value ($) by Country (2015-2020)
Figure Europe Beta-Thal Disease Market PEST Analysis
Table Asia-Pacific Beta-Thal Disease Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Asia-Pacific Beta-Thal Disease Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Asia-Pacific Beta-Thal Disease Import and Export from 2015-2020
Table Asia-Pacific Beta-Thal Disease Value ($) by Type (2015-2020)
Table Asia-Pacific Beta-Thal Disease Production by Type (2015-2020)
Table Asia-Pacific Beta-Thal Disease Consumption by Application (2015-2020)
Table Asia-Pacific Beta-Thal Disease Consumption by Country (2015-2020)
Table Asia-Pacific Beta-Thal Disease Consumption Value ($) by Country (2015-2020)
Figure Asia-Pacific Beta-Thal Disease Market PEST Analysis
Table Latin America Beta-Thal Disease Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Latin America Beta-Thal Disease Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Latin America Beta-Thal Disease Import and Export from 2015-2020
Table Latin America Beta-Thal Disease Value ($) by Type (2015-2020)
Table Latin America Beta-Thal Disease Production by Type (2015-2020)
Table Latin America Beta-Thal Disease Consumption by Application (2015-2020)
Table Latin America Beta-Thal Disease Consumption by Country (2015-2020)
Table Latin America Beta-Thal Disease Consumption Value ($) by Country (2015-2020)
Figure Latin America Beta-Thal Disease Market PEST Analysis
Table Middle East & Africa Beta-Thal Disease Production, Ex-factory Price Revenue ($), Gross Margin (%) and Gross ($) Analysis from 2015-2020
Table Middle East & Africa Beta-Thal Disease Consumption, Terminal Price, Consumption Value ($) and Channel Margin Analysis from 2015-2020
Table Middle East & Africa Beta-Thal Disease Import and Export from 2015-2020
Table Middle East & Africa Beta-Thal Disease Value ($) by Type (2015-2020)
Table Middle East & Africa Beta-Thal Disease Production by Type (2015-2020)
Table Middle East & Africa Beta-Thal Disease Consumption by Application (2015-2020)
Table Middle East & Africa Beta-Thal Disease Consumption by Country (2015-2020)
Table Middle East & Africa Beta-Thal Disease Consumption Value ($) by Country (2015-2020)
Figure Middle East & Africa Beta-Thal Disease Market PEST Analysis
Table Global Beta-Thal Disease Value ($) and Growth Rate Forecast by Region (2020-2027)
Table Global Beta-Thal Disease Production and Growth Rate Forecast by Region (2020-2027)
Table Global Beta-Thal Disease Consumption and Growth Rate Forecast by Region (2020-2027)
Table Global Beta-Thal Disease Production and Growth Rate Forecast by Type (2020-2027)
Table Global Beta-Thal Disease Consumption and Growth Rate Forecast by Application (2020-2027)